June 24, 2022 in Kineta Press Release

Kineta Announces Strategic Research Collaboration and License Agreement with Merck Focused on Accelerating the Development of New Treatments for Neurodegenerative Diseases

Kineta Announces Strategic Research Collaboration and License Agreement with Merck Focused on Accelerating the Development of New Treatments for Neurodegenerative DiseasesStrategic Alliance Combines  ...

Read More